daratumumabisatuximabMezagitamabanti-CD38 monoclonal antibodiessystemic lupus erythematosusautoimmune diseasehematologic malignanciesAAALAC-approved facilityimmune rejection
… allogeneic CAR T cells.References Casneuf T, et al. Effects of daratumumab on natural killer cells and impact on clinical outcomes in rela…